Cooperative Agreement to Support the Foodborne Disease Burden Epidemiology Reference Group of the World Health Organization (U18), 55793-55795 [2010-22863]
Download as PDF
<![CDATA[
55793
Federal Register / Vol. 75, No. 177 / Tuesday, September 14, 2010 / Notices
The case plan is a written document
that provides a narrative description of
the child-specific program of care.
Federal regulations at 45 CFR 1356.21(g)
and section 475(1) of the Act delineate
the specific information that should be
addressed in the case plan. The
Administration for Children and
Families (ACF) does not specify a
recordkeeping format for the case plan
nor does ACF require submission of the
document to the Federal government.
Number of
respondents
Instrument
Case Plan ..................................................................................................
Estimated Total Annual Burden
Hours: 2,891,169.
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Administration, Office of Information
Services, 370 L’Enfant Promenade, SW.,
Washington, DC 20447, Attn: ACF
Reports Clearance Officer. All requests
should be identified by the title of the
information collection. E-mail address:
infocollection@acf.hhs.gov.
OMB Comment
OMB is required to make a decision
concerning the collection of information
between 30 and 60 days after
publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication. Written comments and
recommendations for the proposed
information collection should be sent
directly to the following: Office of
Management and Budget, Paperwork
Reduction Project, Fax: 202–395–7285,
E-mail:
OIRA_SUBMISSION@OMB.EOP.GOV,
Attn: Desk Officer for the
4.79
BILLING CODE 4184–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Health Resources
and Services Administration (HRSA)
publishes abstracts of information
collection requests under review by the
Office of Management and Budget
(OMB), in compliance with the
Paperwork Reduction Act of 1995 (44
U.S.C. Chapter 35). To request a copy of
the clearance requests submitted to
OMB for review, e-mail
paperwork@hrsa.gov or call the HRSA
Reports Clearance Office on (301) 443–
1129.
Average number of responses per
respondent
In order to help carry out its mission,
the Office for the Advancement of
Telehealth (OAT) created a set of
performance measures that grantees can
use to evaluate the effectiveness of their
services programs and monitor their
progress through the use of performance
reporting data. As required by the
Government Performance and Review
Act of 1993 (GPRA), all Federal agencies
must develop strategic plans describing
their overall goal and objectives. OAT
has worked with its grantees to develop
performance measures to be used to
evaluate and monitor the progress of the
grantees. Grantee goals are to: improve
access to needed services; reduce rural
practitioner isolation; improve health
system productivity and efficiency; and
improve patient outcomes. In each of
these categories, specific indicators
were designed to be reported through a
performance monitoring Web site.
The estimates of burden are as
follows:
Total
responses
2
Hours per
response
1,334
7
[FR Doc. 2010–22797 Filed 9–13–10; 8:45 am]
9,338
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Docket No. FDA–2010–N–0466]
BILLING CODE 4165–15–P
Food and Drug Administration
Cooperative Agreement to Support the
Foodborne Disease Burden
Epidemiology Reference Group of the
World Health Organization (U18)
ACTION:
Jkt 220001
Total burden
hours
Dated: September 7, 2010.
Sahira Rafiullah,
Director, Division of Policy and Information
Coordination.
Food and Drug Administration,
HHS.
16:38 Sep 13, 2010
2,891,169
HRSA Telehealth Outcome Measures
(OMB No. 0915–0311)—Extension
AGENCY:
VerDate Mar<15>2010
Total burden
hours
The following request has been
submitted to the Office of Management
and Budget for review under the
Paperwork Reduction Act of 1995:
[FR Doc. 2010–22788 Filed 9–13–10; 8:45 am]
667
Average
burden hours
per response
1
Dated: September 7, 2010.
Robert Sargis,
Reports Clearance Officer.
Performance Measurement Tool .........................................
jlentini on DSKJ8SOYB1PROD with NOTICES
603,453
Number of
respondents
Written comments and
recommendations concerning the
proposed information collection should
be sent within 30 days of this notice to
the desk officer for HRSA, either by email to OIRA_submission@omb.eop.gov
or by fax to 202–395–6974. Please direct
all correspondence to the ‘‘attention of
the desk officer for HRSA.’’
Number of
responses per
respondent
Administration for Children and
Families.
Form
Case plan information is recorded in a
format developed and maintained by the
State or Tribal child welfare agency.
Respondents: State and Tribe title IV–
B and title IV–E agencies.
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
E:\FR\FM\14SEN1.SGM
Notice.
14SEN1
55794
Federal Register / Vol. 75, No. 177 / Tuesday, September 14, 2010 / Notices
The Food and Drug
Administration (FDA) is announcing its
intention to receive and consider a
single source application for the award
of a cooperative agreement in fiscal year
2010 (FY10) to the World Health
Organization (WHO). One of the
primary goals of the WHO is to provide
for timely collaboration on
multinational cooperative activities.
DATES: Important dates are as follows:
1. The application due date is
September 16, 2010.
2. The anticipated start date is
September 2010.
3. The opening date is September 16,
2010.
4. The expiration date is September
30, 2010.
FOR FURTHER INFORMATION CONTACT:
Center Contact: Salvatore Evola, Center
for Food Safety and Applied Nutrition
(HFS–300), 5100 Paint Branch Pkwy.,
College Park, MD 20740, 301–436–2164,
e-mail: evola.salvatore@fda.hhs.gov.
Grants Management Contact:
Kimberly Pendleton, Division of
Acquisition Support and Grants (HFA–
500), Food and Drug Administration,
5630 Fishers Lane, rm. 2104, Rockville,
MD 20857, 301–827–9363, FAX: 301–
827–7101, e-mail:
Kimberly.Pendleton@fda.hhs.gov.
For more information on this funding
opportunity announcement (FOA) and
to obtain detailed requirements, please
refer to the full FOA located at https://
www.fda.gov/Food/NewsEvents/
ucm176500.htm.
SUMMARY:
SUPPLEMENTARY INFORMATION:
I. Funding Opportunity Description
Catalog of Federal Domestic Assistance
Number: 93.103
A. Background
jlentini on DSKJ8SOYB1PROD with NOTICES
This funding opportunity is a single
source application for the award of a
cooperative agreement to the WHO to
support the Initiative to Estimate the
Global Burden of Foodborne Diseases—
Foodborne Disease Burden
Epidemiology Reference Group (FERG).
This cooperative agreement ensures
FDA’s participation and leadership in
important international risk assessment
and public health efforts involving
microbiological and chemical hazards.
Competition is limited to WHO because
it is the parent organization of FERG.
B. Research Objectives
The WHO’s FERG comprises over 30
internationally renowned experts in a
broad range of disciplines relevant to
global foodborne disease epidemiology.
FERG consists of the following
groups:
VerDate Mar<15>2010
16:38 Sep 13, 2010
Jkt 220001
• a Core (or Steering) Group to
coordinate and oversee the scientific
work;
• four different Thematic Task Forces
advancing the work in specific areas:
Infectious diseases, chemicals and
toxins, source attribution, and country
burden of disease protocols; and
• external resource advisers who are
invited on an ad hoc basis to provide
specific expertise.
FERG is charged with the following
tasks:
• assemble, appraise, and report on
the current, the projected, and the
averted burden of foodborne disease
estimates;
• conduct epidemiological reviews
for mortality, morbidity, and disability
in each of the major foodborne diseases;
• provide models for the estimation
of foodborne disease burden where data
are lacking;
• develop cause attribution models to
estimate the proportion of diseases that
are foodborne; and, most importantly,
• use the FERG models to develop
user-friendly tools for burden of
foodborne disease studies at country
level.
In addition, FERG aims to estimate
the global human health burden
(expressed in Disability-Adjusted Life
Years (DALYs)) of foodborne disease.
FERG will initially focus on microbial,
parasitic, zoonotic, and chemical
contamination of food with an emphasis
on diseases whose incidence and
severity is thought to be high, and on
pathogens and chemicals that are most
likely to contaminate food and which
have a high degree of preventability.
FERG is supported by the WHO
Secretariat, comprising nine WHO
Departments as well as international
organizations (such as FAO, United
Nations Environment Programme etc.)
with an interest in foodborne disease
burden estimation.
This agreement will strengthen and
allow WHO to continue its work in
important international risk assessment
and public health efforts. This
agreement will also assist FDA in future
assessments of the potential hazards,
risks, and public health impact of
foodborne disease. WHO is an umbrella
organization that provides for timely
international collaboration on
multinational cooperative activities. The
evaluations that are produced by WHO
expert groups are based on sound
science that contributes to improved
public health and food safety
worldwide. The following activities are
to be supported by this cooperative
agreement: (1) Schedule, plan, and
conduct appropriate work groups,
consultations, and committee meetings;
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
(2) identify advisers, and prepare
written working papers summarizing
the data on foodborne contaminants
under consideration; and (3) prepare
written working papers and technical
documents for the FAO/WHO Expert
Consultations related to contaminants
(microbiological and chemical) in food.
C. Eligibility Information
Competition is limited to WHO
because it has unique expertise and
capacity found nowhere else. As part of
the implementation of the WHO Global
Strategy for Food Safety, WHO launched
the Initiative to Estimate the Global
Burden of Foodborne Diseases from all
major causes (of microbiological,
parasitic, and chemical origin) and in
2007 established FERG to estimate the
global health burden of foodborne
disease (and to express the estimate in
DALYs) (https://www.who.int/
foodsafety/foodborne_disease/ferg).
(FDA has verified the Web site address,
but FDA is not responsible for any
subsequent changes to the Web site after
this document publishes in the Federal
Register.) FERG is a multisectoral and
multidisciplinary group of global
experts in foodborne diseases and
representatives from numerous UN and
other international agencies as well as
National bodies (including the U.S.
agencies FDA, United States Department
of Agriculture and Centers for Disease
Control and Prevention, among others).
FERG operates through several Task
Forces in the area of parasitic diseases,
enteric diseases, chemicals and toxins,
and source attribution (the latter aims to
provide evidence that links burden of
disease to specific food commodities,
where possible). While FERG is
reviewing all existing scientific
evidence, including surveillance data,
the full picture of the global health
burden of foodborne disease can only be
established if national level estimates of
the health burden of foodborne disease
are collected. FERG therefore launched
the Country Studies Task Force which
aims to strengthen the capacity of
countries to undertake national burden
of foodborne disease assessments, and
provides countries with tools with
which to conduct these studies and
continue to monitor disease burden in
the long-term. A further strength of such
data lies in its ability to assist countries
to detect important food safety threats
early and to make and apply food safety
policies and interventions based on
sound scientific evidence pertinent to
that country. WHO aims to conduct
such studies in all six regions over the
coming years.
E:\FR\FM\14SEN1.SGM
14SEN1
Federal Register / Vol. 75, No. 177 / Tuesday, September 14, 2010 / Notices
II. Award Information/Funds Available
A. Award Amount
The estimated amount of support in
FY10 will be up to $100,000 total costs
(direct plus indirect costs), with the
possibility of 2 additional years of
support for a total (over 3 years) of up
to $300,000, subject to the availability of
funds.
B. Length of Support
The award will provide 1 year of
support, with the possibility of 2
additional years of support, contingent
upon satisfactory performance in the
achievement of project and program
reporting objectives during the
preceding year and the availability of
Federal fiscal year appropriations.
jlentini on DSKJ8SOYB1PROD with NOTICES
III. Paper Application, Registration,
and Submission Information
To submit a paper application in
response to this FOA, applicants should
first review the full announcement
located at https://www.fda.gov. Persons
interested in applying for a grant may
obtain an application at https://
grants.nih.gov/grants/forms.htm. (FDA
has verified the Web site address, but
FDA is not responsible for any
subsequent changes to the Web site after
this document publishes in the Federal
Register.) For all paper application
submissions, the following steps are
required:
• Step 1: Obtain a Dun and Bradstreet
(DUNS) Number
• Step 2: Register With Central
Contractor Registration
• Step 3: Register With Electronic
Research Administration (eRA)
Commons
Steps 1 and 2, in detail, can be found
at https://www07.grants.gov/applicants/
organization_registration.jsp. Step 3, in
detail, can be found at https://
commons.era.nih.gov/commons/
registration/registrationInstructions.jsp.
After you have followed these steps,
submit paper applications to: Kimberly
Pendleton, Division of Acquisition
Support and Grants (HFA–500), Food
and Drug Administration, 5630 Fishers
Lane, rm. 2104, Rockville, MD 20857,
301–827–9363, FAX: 301–827–7101, email: Kimberly.Pendleton@fda.hhs.gov.
Dated: September 9, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010–22863 Filed 9–13–10; 8:45 am]
BILLING CODE 4160–01–S
VerDate Mar<15>2010
16:38 Sep 13, 2010
Jkt 220001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Current List of Laboratories Which
Meet Minimum Standards To Engage in
Urine Drug Testing for Federal
Agencies
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice.
AGENCY:
The Department of Health and
Human Services (HHS) notifies Federal
agencies of the laboratories currently
certified to meet the standards of
Subpart C of the Mandatory Guidelines
for Federal Workplace Drug Testing
Programs (Mandatory Guidelines). The
Mandatory Guidelines were first
published in the Federal Register on
April 11, 1988 (53 FR 11970), and
subsequently revised in the Federal
Register on June 9, 1994 (59 FR 29908),
on September 30, 1997 (62 FR 51118),
and on April 13, 2004 (69 FR 19644).
A notice listing all currently certified
laboratories is published in the Federal
Register during the first week of each
month. If any laboratory’s certification
is suspended or revoked, the laboratory
will be omitted from subsequent lists
until such time as it is restored to full
certification under the Mandatory
Guidelines.
If any laboratory has withdrawn from
the HHS National Laboratory
Certification Program (NLCP) during the
past month, it will be listed at the end,
and will be omitted from the monthly
listing thereafter.
This notice is also available on the
Internet at https://
www.workplace.samhsa.gov and https://
www.drugfreeworkplace.gov.
FOR FURTHER INFORMATION CONTACT: Mrs.
Giselle Hersh, Division of Workplace
Programs, SAMHSA/CSAP, Room
2–1042, One Choke Cherry Road,
Rockville, Maryland 20857; 240–276–
2600 (voice), 240–276–2610 (fax).
SUPPLEMENTARY INFORMATION: The
Mandatory Guidelines were developed
in accordance with Executive Order
12564 and section 503 of Public Law
100–71. Subpart C of the Mandatory
Guidelines, ‘‘Certification of
Laboratories Engaged in Urine Drug
Testing for Federal Agencies,’’ sets strict
standards that laboratories must meet in
order to conduct drug and specimen
validity tests on urine specimens for
Federal agencies. To become certified,
an applicant laboratory must undergo
three rounds of performance testing plus
an on-site inspection. To maintain that
SUMMARY:
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
55795
certification, a laboratory must
participate in a quarterly performance
testing program plus undergo periodic,
on-site inspections.
Laboratories which claim to be in the
applicant stage of certification are not to
be considered as meeting the minimum
requirements described in the HHS
Mandatory Guidelines. A laboratory
must have its letter of certification from
HHS/SAMHSA (formerly: HHS/NIDA)
which attests that it has met minimum
standards.
In accordance with Subpart C of the
Mandatory Guidelines dated April 13,
2004 (69 FR 19644), the following
laboratories meet the minimum
standards to conduct drug and specimen
validity tests on urine specimens:
ACL Laboratories, 8901 W. Lincoln
Ave., West Allis, WI 53227, 414–328–
7840/800–877–7016 (Formerly:
Bayshore Clinical Laboratory).
ACM Medical Laboratory, Inc., 160
Elmgrove Park, Rochester, NY 14624,
585–429–2264.
Advanced Toxicology Network, 3560
Air Center Cove, Suite 101, Memphis,
TN 38118, 901–794–5770/888–290–
1150.
Aegis Analytical Laboratories, 345 Hill
Ave., Nashville, TN 37210, 615–255–
2400 (Formerly: Aegis Sciences
Corporation, Aegis Analytical
Laboratories, Inc.).
Alere Toxicology Services, 1111 Newton
St., Gretna, LA 70053, 504–361–8989/
800–433–3823 (Formerly: Kroll
Laboratory Specialists, Inc.,
Laboratory Specialists, Inc.).
Alere Toxicology Services, 450
Southlake Blvd., Richmond, VA
23236, 804–378–9130 (Formerly:
Kroll Laboratory Specialists, Inc.,
Scientific Testing Laboratories, Inc.;
Kroll Scientific Testing Laboratories,
Inc.).
Baptist Medical Center-Toxicology
Laboratory, 11401 I–30, Little Rock,
AR 72209–7056, 501–202–2783
(Formerly: Forensic Toxicology
Laboratory Baptist Medical Center).
Clinical Reference Lab, 8433 Quivira
Road, Lenexa, KS 66215–2802, 800–
445–6917.
Doctors Laboratory, Inc., 2906 Julia
Drive, Valdosta, GA 31602, 229–671–
2281, DrugScan, Inc., P.O. Box 2969,
1119 Mearns Road, Warminster, PA
18974, 215–674–9310.
DynaLIFE Dx *, 10150–102 St., Suite
200, Edmonton, Alberta, Canada T5J
5E2, 780–451–3702/800–661–9876
(Formerly: Dynacare Kasper Medical
Laboratories).
ElSohly Laboratories, Inc., 5 Industrial
Park Drive, Oxford, MS 38655, 662–
236–2609.
E:\FR\FM\14SEN1.SGM
14SEN1
]]>Agencies
[Federal Register Volume 75, Number 177 (Tuesday, September 14, 2010)]
[Notices]
[Pages 55793-55795]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-22863]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2010-N-0466]
Cooperative Agreement to Support the Foodborne Disease Burden
Epidemiology Reference Group of the World Health Organization (U18)
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
[[Page 55794]]
SUMMARY: The Food and Drug Administration (FDA) is announcing its
intention to receive and consider a single source application for the
award of a cooperative agreement in fiscal year 2010 (FY10) to the
World Health Organization (WHO). One of the primary goals of the WHO is
to provide for timely collaboration on multinational cooperative
activities.
DATES: Important dates are as follows:
1. The application due date is September 16, 2010.
2. The anticipated start date is September 2010.
3. The opening date is September 16, 2010.
4. The expiration date is September 30, 2010.
FOR FURTHER INFORMATION CONTACT: Center Contact: Salvatore Evola,
Center for Food Safety and Applied Nutrition (HFS-300), 5100 Paint
Branch Pkwy., College Park, MD 20740, 301-436-2164, e-mail:
evola.salvatore@fda.hhs.gov.
Grants Management Contact: Kimberly Pendleton, Division of
Acquisition Support and Grants (HFA-500), Food and Drug Administration,
5630 Fishers Lane, rm. 2104, Rockville, MD 20857, 301-827-9363, FAX:
301-827-7101, e-mail: Kimberly.Pendleton@fda.hhs.gov.
For more information on this funding opportunity announcement (FOA)
and to obtain detailed requirements, please refer to the full FOA
located at https://www.fda.gov/Food/NewsEvents/ucm176500.htm.
SUPPLEMENTARY INFORMATION:
I. Funding Opportunity Description
Catalog of Federal Domestic Assistance Number: 93.103
A. Background
This funding opportunity is a single source application for the
award of a cooperative agreement to the WHO to support the Initiative
to Estimate the Global Burden of Foodborne Diseases--Foodborne Disease
Burden Epidemiology Reference Group (FERG). This cooperative agreement
ensures FDA's participation and leadership in important international
risk assessment and public health efforts involving microbiological and
chemical hazards. Competition is limited to WHO because it is the
parent organization of FERG.
B. Research Objectives
The WHO's FERG comprises over 30 internationally renowned experts
in a broad range of disciplines relevant to global foodborne disease
epidemiology.
FERG consists of the following groups:
a Core (or Steering) Group to coordinate and oversee the
scientific work;
four different Thematic Task Forces advancing the work in
specific areas: Infectious diseases, chemicals and toxins, source
attribution, and country burden of disease protocols; and
external resource advisers who are invited on an ad hoc
basis to provide specific expertise.
FERG is charged with the following tasks:
assemble, appraise, and report on the current, the
projected, and the averted burden of foodborne disease estimates;
conduct epidemiological reviews for mortality, morbidity,
and disability in each of the major foodborne diseases;
provide models for the estimation of foodborne disease
burden where data are lacking;
develop cause attribution models to estimate the
proportion of diseases that are foodborne; and, most importantly,
use the FERG models to develop user-friendly tools for
burden of foodborne disease studies at country level.
In addition, FERG aims to estimate the global human health burden
(expressed in Disability-Adjusted Life Years (DALYs)) of foodborne
disease. FERG will initially focus on microbial, parasitic, zoonotic,
and chemical contamination of food with an emphasis on diseases whose
incidence and severity is thought to be high, and on pathogens and
chemicals that are most likely to contaminate food and which have a
high degree of preventability.
FERG is supported by the WHO Secretariat, comprising nine WHO
Departments as well as international organizations (such as FAO, United
Nations Environment Programme etc.) with an interest in foodborne
disease burden estimation.
This agreement will strengthen and allow WHO to continue its work
in important international risk assessment and public health efforts.
This agreement will also assist FDA in future assessments of the
potential hazards, risks, and public health impact of foodborne
disease. WHO is an umbrella organization that provides for timely
international collaboration on multinational cooperative activities.
The evaluations that are produced by WHO expert groups are based on
sound science that contributes to improved public health and food
safety worldwide. The following activities are to be supported by this
cooperative agreement: (1) Schedule, plan, and conduct appropriate work
groups, consultations, and committee meetings; (2) identify advisers,
and prepare written working papers summarizing the data on foodborne
contaminants under consideration; and (3) prepare written working
papers and technical documents for the FAO/WHO Expert Consultations
related to contaminants (microbiological and chemical) in food.
C. Eligibility Information
Competition is limited to WHO because it has unique expertise and
capacity found nowhere else. As part of the implementation of the WHO
Global Strategy for Food Safety, WHO launched the Initiative to
Estimate the Global Burden of Foodborne Diseases from all major causes
(of microbiological, parasitic, and chemical origin) and in 2007
established FERG to estimate the global health burden of foodborne
disease (and to express the estimate in DALYs) (https://www.who.int/foodsafety/foodborne_disease/ferg). (FDA has verified the Web site
address, but FDA is not responsible for any subsequent changes to the
Web site after this document publishes in the Federal Register.) FERG
is a multisectoral and multidisciplinary group of global experts in
foodborne diseases and representatives from numerous UN and other
international agencies as well as National bodies (including the U.S.
agencies FDA, United States Department of Agriculture and Centers for
Disease Control and Prevention, among others). FERG operates through
several Task Forces in the area of parasitic diseases, enteric
diseases, chemicals and toxins, and source attribution (the latter aims
to provide evidence that links burden of disease to specific food
commodities, where possible). While FERG is reviewing all existing
scientific evidence, including surveillance data, the full picture of
the global health burden of foodborne disease can only be established
if national level estimates of the health burden of foodborne disease
are collected. FERG therefore launched the Country Studies Task Force
which aims to strengthen the capacity of countries to undertake
national burden of foodborne disease assessments, and provides
countries with tools with which to conduct these studies and continue
to monitor disease burden in the long-term. A further strength of such
data lies in its ability to assist countries to detect important food
safety threats early and to make and apply food safety policies and
interventions based on sound scientific evidence pertinent to that
country. WHO aims to conduct such studies in all six regions over the
coming years.
[[Page 55795]]
II. Award Information/Funds Available
A. Award Amount
The estimated amount of support in FY10 will be up to $100,000
total costs (direct plus indirect costs), with the possibility of 2
additional years of support for a total (over 3 years) of up to
$300,000, subject to the availability of funds.
B. Length of Support
The award will provide 1 year of support, with the possibility of 2
additional years of support, contingent upon satisfactory performance
in the achievement of project and program reporting objectives during
the preceding year and the availability of Federal fiscal year
appropriations.
III. Paper Application, Registration, and Submission Information
To submit a paper application in response to this FOA, applicants
should first review the full announcement located at https://www.fda.gov. Persons interested in applying for a grant may obtain an
application at https://grants.nih.gov/grants/forms.htm. (FDA has
verified the Web site address, but FDA is not responsible for any
subsequent changes to the Web site after this document publishes in the
Federal Register.) For all paper application submissions, the following
steps are required:
Step 1: Obtain a Dun and Bradstreet (DUNS) Number
Step 2: Register With Central Contractor Registration
Step 3: Register With Electronic Research Administration
(eRA) Commons
Steps 1 and 2, in detail, can be found at https://www07.grants.gov/applicants/organization_registration.jsp. Step 3, in detail, can be
found at https://commons.era.nih.gov/commons/registration/registrationInstructions.jsp. After you have followed these steps,
submit paper applications to: Kimberly Pendleton, Division of
Acquisition Support and Grants (HFA-500), Food and Drug Administration,
5630 Fishers Lane, rm. 2104, Rockville, MD 20857, 301-827-9363, FAX:
301-827-7101, e-mail: Kimberly.Pendleton@fda.hhs.gov.
Dated: September 9, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-22863 Filed 9-13-10; 8:45 am]
BILLING CODE 4160-01-S
